Messages From the Director
Messages from the Director
February 2012
November 2011
September 2011
August 2011
June 2011
May 2011
February 2011
January 2011
December 2010
October 2010
December 2009
February 2009
December 2008
January 2008
February 2007
October 2005
September 2005
August 2005
Mourning the Passing of Dr. William Pollin
January 2008
Many of our NIDA and NIMH colleagues join us in mourning the passing of noted psychiatrist and former NIDA director Dr. William Pollin, on January 25 at the age of 85. Dr. Pollin was NIDA's second director, from 1975-1985 and on staff at NIMH from 1956-1971.
Over his long career, Dr. Pollin made many notable contributions to psychiatry and to drug control policy. At NIMH he contributed to early studies which examined pairs of twins to determine the connection between development of schizophrenia and obstetrical complications and various other neurological abnormalities. At NIDA he was one of the key researchers who changed the medical view of tobacco smoking from an unhealthy habit to a diagnosable drug addiction—after which cigarette makers nicknamed him "Doctor Death" to the tobacco industry. Dr. Pollin emphasized supporting family-oriented drug prevention programs and during this time the rate of cannabis abuse in high school children declined.
Dr. Pollin's passing reminds us that NIH's success has been built not only on the scientific excellence of those who came before us but also on their public health vision. Funeral services for Dr. Pollin were held on Monday, January 28. The Washington Post had an interesting article on Dr. Pollin on January 31; for your convenience were are including the link.
Sincerely,
Nora D. Volkow, M.D.
Director
This page was last updated January 2008.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
External link, please review our disclaimer.
External link, please review our disclaimer.
External link, please review our disclaimer.





